NxStage’s updated System One hemodialysis system gets CE mark

March 7, 2017
NxStage Medical Inc.’s next generation System One hemodialysis system has received the CE mark in Europe. The system consists of new…

NxStage names Allan Collins as CMO

March 1, 2017
Dialysis product manufacturer NxStage Medical Inc. has named Allan Collins, MD, FACP chief medical officer. In this new role, Collins will lead a new…

Peritoneal dialysis growth in the U.S. encounters unexpected hurdles

February 23, 2017
Home dialysis therapies—both peritoneal dialysis (PD) and home hemodialysis (HHD)—are important treatment options for patients with stage…

Baxter presents positive data on peritoneal dialysis technology at Kidney Week

November 22, 2016
Baxter International Inc. presented data at the American Society of Nephrology’s 2016 Kidney Week that indicates its Sharesource telehealth…

ASN Kidney Week 2016 product gallery

November 14, 2016
Updated products introduced to the renal community in 2016 that will be on display during Kidney Week.  

Baxter begins clinical trial of citrate anticoagulant for use during CRRT

November 13, 2016
Baxter International Inc. has started a Phase 3 clinical trial evaluating an investigational drug that combines a citrate anticoagulant and renal…

Outcomes among patients receiving in-center, self-care hemodialysis

October 5, 2016
Modalities of renal replacement therapy are categorized into in-center hemodialysis and home therapies. A subset of hemodialysis patients referred to…

Satellite to begin using NxStage's Nx2me Connected Health platform

October 4, 2016
Satellite Healthcare has signed a three-year agreement with NxStage Medical Inc. that includes NxStage's Nx2me Connected Health platform for their…

Making the case for in-center, self-care hemodialysis

September 13, 2016
Conventional in-center hemodialysis is the modality used by approximately 90% of patients receiving dialysis in the U.S.1  For patients and…

Every other day nocturnal home hemodialysis: An alternative approach to reduce burden

August 30, 2016
More frequent dialysis, typically performed five to six times per week at home, has been associated with a number of clinical, cardiovascular, and…

An inside look at the UAB home dialysis telemedicine pilot

August 10, 2016
The University of Alabama at Birmingham Medicine’s Red Mountain Home Dialysis Training Unit is piloting a three-year telemedicine trial for

ACE inhibitors, ARBs linked to similar results in peritoneal dialysis patients

August 8, 2016
A new study examined two classes of medications commonly prescribed to prevent cardiovascular events in end-stage renal disease patients on…

Study associates Baxter’s Revaclear dialyzer with less need for ESAs during hemodialysis

July 27, 2016
Baxter International Inc.’s Revaclear dialyzer was associated with lower use of erythropoiesis-stimulating agent, according to an observational…

Baxter dialysis sales up 2% in second quarter

July 26, 2016
Sales of dialysis products from Baxter International’s Renal division totaled $965 million in the second quarter, representing a 2% increase on…

Home and more frequent dialysis at the fore of Medicare dialysis rulemaking

July 11, 2016
Editor’s Note: The Centers for Medicare & Medicaid Services released its 2017 proposed rule for the Prospective Payment System and Quality

Exit of Baxter in home hemodialysis market could slow modality’s expansion

July 6, 2016
It’s lonely at the top. As the sole manufacturer of a portable home hemodialysis machine in the U.S. market, NxStage Medical may not see things…

Baxter nixes Vivia home hemodialysis machine

June 21, 2016
Baxter Renal Care has pulled the plug on clinical trials in Canada and in the U.S. for its Vivia home hemodialysis machine. Manufacturing of the…

Baxter appoints interim renal business president

June 19, 2016
Baxter International Inc.’s renal business president Jill Schaaf has stepped down, the company announced last month, placing Giuseppe Accogli

Blood pressure medications reduce stroke and heart attack in peritoneal dialysis patients

June 15, 2016
Two classes of blood pressure medications, angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs), are…

Education key to increasing home dialysis

May 3, 2016
Out of the ten largest U.S. dialysis providers, Satellite Healthcare has the largest number of its dialysis patients using home therapies…